trending Market Intelligence /marketintelligence/en/news-insights/trending/STwO6DeYHkSY3GxrKiAR7A2 content esgSubNav
In This List

Merck & Co. animal health unit acquires Icelandic fish tech company from Pentair

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Merck & Co. animal health unit acquires Icelandic fish tech company from Pentair

Merck & Co. Inc.'s animal health division completed its acquisition of Vaki, a fish monitoring equipment maker, from water treatment company Pentair PLC.

Kenilworth, N.J.-based Merck did not disclose financial details of the deal.

Merck Animal Health said the acquisition expands its aquaculture portfolio to include precision farming and fish welfare solutions, which complement the company's portfolio of vaccines and pharmaceuticals.

Kópavogur, Iceland-based Vaki will be housed under Merck Animal Health's Biomark business, which specializes in electronic identification technology used in fisheries, wildlife and aquaculture research.

In April, Merck acquired animal identification company Antelliq Corp. from funds advised by London-based BC Partners for about €2.1 billion.